Omega Healthcare (OHI) Chief Legal Officer Gail D. Makode Exercises Derivatives

What Happened
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors, recorded the exercise/conversion of derivative interests on 2026-09-30. The filing shows conversion/acquisition of 14,862 and 5,620 units (total 20,482) and matching disposals of the same amounts, with a reported exercise/conversion price of $0.00 (derivative transactions coded "M"). No cash exercise price is reported in the Form 4 excerpt provided.

Key Details

• Transaction date: 2026-09-30 (Form filed same day) — appears to be timely.
• Transaction type/code: Exercise/conversion of derivative (code M).
• Units involved: 14,862 and 5,620 (total 20,482); both acquired and disposed on the same date.
• Price/value: $0.00 reported as the exercise/conversion price; the filing does not state cash proceeds or FMV realized.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes:
  • F1: These were Profits Interest Units (PIUs) in the Operating Partnership that can convert into OP Units upon vesting.
  • F2: OP Units can be redeemed for cash equal to the fair market value per share or, at the issuer’s election, converted into common stock.
  • F3 & F4: The PIUs represented portions vested quarterly in 2026 based on Absolute and Relative Total Shareholder Return for the 2023–2025 performance period (certified Jan 8, 2026).

Context

• This filing reflects a derivative conversion/vesting event rather than an open‑market buy or sale. The simultaneous acquisition and disposition of equal amounts commonly occurs when vested partnership units convert and are immediately redeemed, transferred or otherwise settled; the Form 4 here does not state the post-conversion treatment or cash received.
• For retail investors: conversions and vested awards are routine executive compensation events; they do not necessarily signal a buy/sell decision by the insider.